Cargando…

Adequacy of safety data for regulatory approval of pediatric indication through extrapolation algorithm

Detalles Bibliográficos
Autor principal:	Park, Min Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Clinical Pharmacology and Therapeutics 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255546/ https://www.ncbi.nlm.nih.gov/pubmed/34235119 http://dx.doi.org/10.12793/tcp.2021.29.e11

Ejemplares similares

How to compare adequacy of algorithms to control blood glucose in the intensive care unit?
por: Van den Berghe, Greet
Publicado: (2004)

Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective
por: Sun, Wellington
Publicado: (2023)

Biosimilar Drugs: What Would Be a Reasonable Extrapolation?
por: Gifoni, Markus A.C., et al.
Publicado: (2017)

A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways
por: Klein, Kevin, et al.
Publicado: (2021)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

Confusion about Cadmium Risks: The Unrecognized Limitations of an Extrapolated Paradigm
por: Bernard, Alfred
Publicado: (2015)

Regulatory innovation for expansion of indications and pediatric drug development
por: Park, Min Soo
Publicado: (2018)

In Vitro‐to‐In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
por: Yu, Jingjing, et al.
Publicado: (2020)

Biosimilars and the extrapolation of indications for inflammatory conditions
por: Tesser, John RP, et al.
Publicado: (2017)

Democratization of genetic data: connecting government approval of clinical tests with data sharing
por: Ross, Theodora S.
Publicado: (2015)

An extrapolation of Foucault’s Technologies of the Self to effect positive transformation in the intensivist as teacher and mentor
por: Papadimos, Thomas J, et al.
Publicado: (2013)

Safety and Adequacy of Percutaneous Biopsies in Pediatric Orthotopic Kidney Transplantation
por: Mackie, F. E., et al.
Publicado: (2012)

Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests
por: Eyal, Nir, et al.
Publicado: (2021)

Extrapolation of carcinogenesis data
por: Lepkowski, Wil
Publicado: (1978)

Impact of different recommendations on adequacy rate for sleep duration in children
por: Bruni, Oliviero, et al.
Publicado: (2017)

Extrapolation of toxic indices among test objects
por: Tichý, Miloň, et al.
Publicado: (2010)

When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Time for a regulatory framework for pediatric medications in Canada
por: Gilpin, Andrea, et al.
Publicado: (2022)

Controversies in Establishing Biosimilarity: Extrapolation of Indications and Global Labeling Practices
por: Ebbers, Hans C., et al.
Publicado: (2016)

Bite-to-needle Time – An Extrapolative Indicator of Repercussion in Patients with Snakebite
por: Jayaraman, Thamizhkumaran, et al.
Publicado: (2022)

Approval and Certification of Ophthalmic AI Devices in the European Union
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution
por: Liang, Aijun, et al.
Publicado: (2023)

Hydroxychloroquine and QT prolongation: reassuring data in approved indications
por: Pareek, Anil, et al.
Publicado: (2020)

Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
por: Maeda, Hideki, et al.
Publicado: (2022)

Palliative Sedation Therapy in Pediatrics: An Algorithm and Clinical Practice Update
por: Cuviello, Andrea, et al.
Publicado: (2022)

Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data
por: Strech, Daniel, et al.
Publicado: (2012)

A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?
por: Zhang, Jie, et al.
Publicado: (2020)

Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation
por: Fleming, Thomas R., et al.
Publicado: (2022)

The challenge of achieving vitamin D adequacy for residents living in long-term care
por: Cammer, Allison L, et al.
Publicado: (2022)

Extrapolation of experimental data from animals to man.
por: Krasovskii, G N
Publicado: (1976)

Extrapolation of measured called release-efficiency data
por: Delahaye, P
Publicado: (24/0)

Extrapolation of animal carcinogenicity data: limitations and pitfalls.
por: Hogan, M D
Publicado: (1983)

On the merging of analyticity and statistics in extrapolations and representations of data
por: Presnajder, P, et al.
Publicado: (1971)

Identifying and characterizing extrapolation in multivariate response data
por: Bartley, Meridith L., et al.
Publicado: (2019)

Safety and Competency are the Main Priorities in Pediatric Endoscopy
por: Choe, Byung-Ho
Publicado: (2020)

The Parametrized Extrapolator
por: Spenko, Kristof
Publicado: (2021)

Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center
por: Lee, Kyoungmin, et al.
Publicado: (2019)

Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab
por: Chertkow, Howard, et al.
Publicado: (2021)

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
por: Blumenthal, Gideon M., et al.
Publicado: (2017)

Time for the US food and drug administration approval of condoms for anal intercourse
por: Nguyen, Brian T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lrip8u9olj9l46o70jh49jb3oo